Financhill
Back

Lumos Pharma Stock Predictions

Lumos Pharma Stock Forecast

  • Is Lumos Pharma Stock Undervalued?
    The current Lumos Pharma [LUMO] share price is $2.20. The Score for LUMO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • LUMO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Lumos Pharma Stock Go Up Next Year?

Data Unavailable

Lumos Pharma Stock Rating

Data Unavailable

Lumos Pharma Stock Price History

Is LUMO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LUMO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lumos-pharma.com

52-Week Data

52-Week High:
4.55
52-Week Low:
2.01

Prediction Charts

Market Cap:
17.86M
Price in USD:
2.20
Volume:
2.18K
Beta:
0.81

Technical Analysis

SMA50:
2.53
SMA100:
2.70
SMA200:
2.97
52-Wk Change:
-30.84%

Stock Predictions

  • Is Lumos Pharma stock public?
    Yes, Lumos Pharma is a publicly traded company.
  • What is the Lumos Pharma stock quote today?
    The Lumos Pharma stock price is 2.20 USD today.
  • How to buy Lumos Pharma stock online?
    You can buy Lumos Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-13 2.46 2.49 2.55 2.46
Jun-14 2.36 2.39 2.52 2.36
Jun-17 2.40 2.30 2.40 2.30
Jun-18 2.30 2.20 2.32 2.17
Jun-20 2.24 2.19 2.24 2.15
Jun-21 2.10 2.23 2.23 2.08
Jun-24 2.25 2.27 2.36 2.20
Jun-25 2.34 2.24 2.34 2.21
Jun-26 2.25 2.26 2.28 2.25
Jun-27 2.25 2.25 2.25 2.23
Jun-28 2.25 2.29 2.30 2.25
Jul-1 2.25 2.26 2.38 2.25
Jul-2 2.32 2.27 2.32 2.17
Jul-3 2.24 2.20 2.28 2.20

Lumos Pharma Earnings

Data Unavailable

Lumos Pharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.19 per share, an increase this year of $0.56 per share, and an increase next year of $1.38 per share.

* Lumos Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.